At Bio SB Inc. our passion is providing biomedical laboratories with the tools to improve the diagnosis, prognosis and therapy prediction that benefit patients worldwide.
Bio SB is proud to develop, manufacture and distribute unique products for Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF), Fluorescent in situ Hybridization (FISH) and Chromogenic in situ Hybridization (CISH) technologies that meet the highest international standards for applications in Molecular Pathology. We conduct business in more than 70 countries, including in the Americas, Europe, Africa, Asia, Australia and the Middle East, to ensure that Bio SB products can reach clinicians, pathologists, researchers, and patients worldwide.
Bio SB has a talented, dedicated, and vibrant team of professionals that excel in the R&D, Production and Marketing of immunochemicals and nucleic acids for Cancer Diagnostics and Research, Microbiology, Immunology and Immunotherapy. Bio SB is a CE/IVDD and ISO 13485:2016 certified company that manufactures and develops products in accordance with USA FDA QSR 21 CFR Part 820 cGMP. These guidelines enable us to produce IVD products that meet the highest in vitro diagnostic standards.
As industry research, genetic sequencing, and explosive growth in genomics pushes molecular pathology forward, Bio SB will continue to offer a large portfolio of products at a competitive price to Laboratories, Clinicians, Researchers and patients worldwide.